BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29030070)

  • 1. A latex agglutination assay to quantify the amount of hemagglutinin protein in adjuvanted low-dose influenza monovalent vaccines.
    Buffin S; Ikhelef N; Prudent J; Dubayle J; Nougarede N; Varenne MP; Moste C; Legastelois I
    J Virol Methods; 2018 Jan; 251():46-53. PubMed ID: 29030070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivated influenza vaccine stress can affect in vitro potency assay relationship to immunogenicity.
    Wen Y; Palladino G; Xie Y; Ferrari A; Settembre EC
    Vaccine; 2018 May; 36(21):3010-3017. PubMed ID: 29680201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays.
    Lorbetskie B; Wang J; Gravel C; Allen C; Walsh M; Rinfret A; Li X; Girard M
    Vaccine; 2011 Apr; 29(18):3377-89. PubMed ID: 21397719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Avian glycan-specific IgM monoclonal antibodies for the detection and quantitation of type A and B haemagglutinins in egg-derived influenza vaccines.
    Legastelois I; Chevalier M; Bernard MC; de Montfort A; Fouque M; Pilloud A; Serraille C; Devard N; Engel O; Sodoyer R; Moste C
    J Virol Methods; 2011 Dec; 178(1-2):129-36. PubMed ID: 21907241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines.
    Schmeisser F; Vasudevan A; Soto J; Kumar A; Williams O; Weir JP
    Influenza Other Respir Viruses; 2014 Sep; 8(5):587-95. PubMed ID: 25087462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of recombinant hemagglutinin proteins as alternative antigen standards for pandemic influenza vaccines.
    Choi Y; Kwon SY; Oh HJ; Shim S; Chang S; Chung HJ; Kim DK; Park Y; Lee Y
    Biotechnol Lett; 2017 Sep; 39(9):1375-1380. PubMed ID: 28612264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination.
    Schmeisser F; Vodeiko GM; Lugovtsev VY; Stout RR; Weir JP
    Vaccine; 2010 Mar; 28(12):2442-9. PubMed ID: 20074687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trypsin pre-treatment corrects SRID over-estimation of immunologically active, pre-fusion HA caused by mixed immunoprecipitin rings.
    Wen Y; Palladino G; Xie Y; Ferrari A; Ma X; Han L; Dormitzer PR; Settembre EC
    Vaccine; 2016 Jun; 34(29):3388-95. PubMed ID: 27154389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical review of current and emerging quantification methods for the development of influenza vaccine candidates.
    Manceur AP; Kamen AA
    Vaccine; 2015 Nov; 33(44):5913-9. PubMed ID: 26271833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines.
    Bodle J; Vandenberg K; Laurie K; Barr IG; Zhang Y; Rockman S
    Front Immunol; 2023; 14():1147028. PubMed ID: 37033922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A; Woerner A; Schmeisser F; Verma S; Williams O; Weir JP
    Influenza Other Respir Viruses; 2018 Mar; 12(2):250-258. PubMed ID: 29152878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.
    Bodle J; Verity EE; Ong C; Vandenberg K; Shaw R; Barr IG; Rockman S
    Influenza Other Respir Viruses; 2013 Mar; 7(2):191-200. PubMed ID: 22583601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines.
    Schmeisser F; Jing X; Joshi M; Vasudevan A; Soto J; Li X; Choudhary A; Baichoo N; Resnick J; Ye Z; McCormick W; Weir JP
    Influenza Other Respir Viruses; 2016 Mar; 10(2):134-40. PubMed ID: 26616263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antibody-independent receptor-binding SPR-based assay for rapid measurement of influenza vaccine potency.
    Khurana S; King LR; Manischewitz J; Coyle EM; Golding H
    Vaccine; 2014 Apr; 32(19):2188-97. PubMed ID: 24613520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and qualification of the parallel line model for the estimation of human influenza haemagglutinin content using the single radial immunodiffusion assay.
    van Kessel G; Geels MJ; de Weerd S; Buijs LJ; de Bruijni MA; Glansbeek HL; van den Bosch JF; Heldens JG; van den Heuvel ER
    Vaccine; 2012 Jan; 30(2):201-9. PubMed ID: 22107849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VaxArray assessment of influenza split vaccine potency and stability.
    Kuck LR; Saye S; Loob S; Roth-Eichhorn S; Byrne-Nash R; Rowlen KL
    Vaccine; 2017 Apr; 35(15):1918-1925. PubMed ID: 28262335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative analyses of all influenza type A viral hemagglutinins and neuraminidases using universal antibodies in simple slot blot assays.
    Gravel C; Li C; Wang J; Hashem AM; Jaentschke B; Van Domselaar G; He R; Li X
    J Vis Exp; 2011 Apr; (50):. PubMed ID: 21490585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformationally selective biophysical assay for influenza vaccine potency determination.
    Wen Y; Han L; Palladino G; Ferrari A; Xie Y; Carfi A; Dormitzer PR; Settembre EC
    Vaccine; 2015 Oct; 33(41):5342-5349. PubMed ID: 26348403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China.
    Li C; Shao M; Cui X; Song Y; Li J; Yuan L; Fang H; Liang Z; Cyr TD; Li F; Li X; Wang J
    Biologicals; 2010 Mar; 38(2):284-9. PubMed ID: 20074976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.